Company news
Anika Therapeutics Inc. (NASDAQ:ANIK) news
Anika Therapeutics Inc. news releases on 6ix. Latest, Jul 29, 2026: Anika Reports Second Quarter 2026 Financial Results
Press releases & updates
Anika Reports Second Quarter 2026 Financial Results
July 29, 2026
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
July 15, 2026
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
April 30, 2026
Anika Reports First Quarter 2026 Financial Results
April 29, 2026
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
April 16, 2026
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
April 14, 2026
Telix Strengthens Board with Additional Director Appointments
April 8, 2026
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
February 18, 2026
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
February 12, 2026
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
February 4, 2026
Anika Therapeutics Announces Leadership Transition
January 8, 2026
Anika Reports Third Quarter 2025 Financial Results
November 5, 2025
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
November 5, 2025
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
October 23, 2025
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 5, 2025
Anika Reports Second Quarter 2025 Financial Results
July 30, 2025
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
July 30, 2025
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
July 16, 2025
Anika Reports First Quarter 2025 Financial Results
May 9, 2025
Anika to Participate in the Sidoti Virtual Investor Conference
May 7, 2025
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
April 25, 2025
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
Anika Completes Divestiture of Parcus Medical
March 7, 2025
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 25, 2025
Anika Reports Third Quarter 2024 Financial Results
October 30, 2024
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 30, 2024
Anika Announces Third Quarter 2024 Results Conference Call Date
October 16, 2024
Anika Reports Second Quarter 2024 Financial Results
August 7, 2024
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 24, 2024
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 10, 2024
Anika Enters into Cooperation Agreement with Caligan Partners
May 27, 2024
Anika Reports First Quarter 2024 Financial Results
May 7, 2024
Anika Announces CFO Transition
May 7, 2024
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 17, 2024
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
March 12, 2024
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 26, 2024
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 27, 2023
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
November 1, 2023
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 9, 2023
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
September 18, 2023
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
August 16, 2023
Anika Reports Second Quarter 2023 Financial Results
August 7, 2023
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 19, 2023
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
May 29, 2023
Anika Reports First Quarter 2023 Financial Results
May 8, 2023
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 18, 2023
Anika Enters Into Cooperation Agreement with Caligan Partners
April 12, 2023
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
April 2, 2023